Shanghai, China

Lingxiang Chen


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):

Title: Lingxiang Chen: Innovator in Pharmaceutical Chemistry

Introduction

Lingxiang Chen is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of piperidine derivatives. His work focuses on innovative solutions for treating estrogen receptor-mediated diseases, including breast cancer.

Latest Patents

Lingxiang Chen holds 2 patents related to his research. His latest patent involves a piperidine derivative and its preparation method, along with its pharmaceutical use. This invention specifically addresses the use of the piperidine derivative as an estrogen receptor modulator, which is crucial in the treatment of conditions related to estrogen receptors. The detailed description of the general formula (I) and its substituents is provided in the patent documentation.

Career Highlights

Throughout his career, Lingxiang Chen has worked with notable companies in the pharmaceutical industry. He has been associated with Jiangsu Hengrui Medicine Company Ltd. and Shanghai Hengrui Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to advance his research and contribute to significant pharmaceutical innovations.

Collaborations

Lingxiang Chen has collaborated with several professionals in his field, including Shanghai Yu and Fanglong Yang. These collaborations have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Lingxiang Chen is a dedicated inventor whose work in pharmaceutical chemistry has the potential to make a significant impact on the treatment of breast cancer and other estrogen receptor-related conditions. His innovative approach and commitment to research continue to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…